Publicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (52)

2024

  1. Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study

    Transplantation

  2. Prevalence and prognostic impact of stroke in a national cohort of infective endocarditis

    International Journal of Stroke

  3. Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIV

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry

    PloS one, Vol. 18, Núm. 9, pp. e0290998

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  5. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

2022

  1. Bartonella Endocarditis in Spain: Case Reports of 21 Cases

    Pathogens, Vol. 11, Núm. 5

  2. Infective Endocarditis in Diabetic Patients: A Different Profile with Prognostic Consequences

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  3. Influenza A-Associated In-Hospital Mortality in Very Older People: Does Inflammation Also Play a Role?

    Gerontology, Vol. 68, Núm. 7, pp. 780-788

  4. Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018

    BMC infectious diseases, Vol. 22, Núm. 1, pp. 379

  5. Multivalvular Endocarditis: A Rare Condition with Poor Prognosis

    Journal of Clinical Medicine, Vol. 11, Núm. 16

  6. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1

  7. Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines

    European Journal of Internal Medicine, Vol. 99, pp. 19-21

2021

  1. Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain

    Heart, Vol. 107, Núm. 21, pp. 1717-1724

  2. Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock

    Clinical Infectious Diseases, Vol. 73, Núm. 5, pp. 765-774

  3. Clinical factors associated with reinfection versus relapse in infective endocarditis: Prospective cohort study

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-12

  4. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

    The Lancet Respiratory Medicine, Vol. 9, Núm. 12, pp. 1407-1418

  5. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130